NovaBay Pharmaceuticals to Present at the Ladenburg Thalmann 2022 Healthcare Conference

NovaBay Pharmaceuticals to Present at the Ladenburg Thalmann 2022 Healthcare Conference


EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that management will present at the Ladenburg Thalmann 2022 Healthcare Conference on Thursday, September 29 at 9:00 a.m. Eastern time (6:00 a.m. Pacific time). The conference is being held at the Sofitel Hotel New York. A webcast of the presentation will be available on the Events page of the company website.

About NovaBay Pharmaceuticals, Inc:

NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells scientifically created and clinically proven consumer products for the eyecare and skincare markets. Avenova® is the most prescribed antimicrobial lid and lash spray and DERMAdoctor® is a premium skincare brand offering more than 30 dermatologist-developed skincare products sold through traditional domestic retailers, digital beauty channels and international distributors.

Socialize and Stay Informed on NovaBays Progress

Like us on Facebook

Follow us on Twitter

Connect with NovaBay on LinkedIn

Visit NovaBay’s Website

Avenova Purchasing Information

For NovaBay Avenova purchasing information:

Please call 800-890-0329 or email [email protected]

DERMAdoctor Purchasing Information

For DERMAdoctor purchasing information:

Please call 877-337-6237 or email [email protected]

NovaBay Contact

Justin Hall

Chief Executive Officer and General Counsel


[email protected]

Investor Contact

LHA Investor Relations

Jody Cain


[email protected]

KEYWORDS: California New York United States North America

INDUSTRY KEYWORDS: Women Biotechnology Pharmaceutical Optical Health Consumer Cosmetics Retail